# Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

> **NCT00796458** · PHASE3 · UNKNOWN · sponsor: **A.O.U. San Giovanni Battista di Torino, Italy** · enrollment: 200 (estimated)

## Conditions studied

- Pain
- Prostate Cancer

## Interventions

- **DRUG:** docetaxel
- **DRUG:** releasing hormone agonist therapy

## Key facts

- **NCT ID:** NCT00796458
- **Lead sponsor:** A.O.U. San Giovanni Battista di Torino, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-04
- **Primary completion:** 2013-10
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796458, "Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00796458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*